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HIGH DIMENSIONAL RANDOM WALKS CAN APPEAR LOW
DIMENSIONAL: APPLICATION TO INFLUENZA H3N2 EVOLUTION
JAMES MOORE AND HASAN AHMED
Abstract. One important feature of the mammalian immune system is the highly spe-
cific binding of antigens to antibodies. Antibodies generated in response to one infection
may also provide some level of cross immunity to other infections. One model to describe
this cross immunity is the notion of antigenic space, which assigns each antibody and each
virus a point in Rn. Past studies have suggested the dimensionality of antigenic space, n,
may be small. In this study we show that data from hemagglutination assays suggest a
high dimensional random walk (or self avoiding random random walk). The discrepancy
between our result and prior studies is due to the fact that random walks can appear low
dimensional according to a variety of analyses. including principal component analysis
(PCA) and multidimensional scaling (MDS).
1. Introduction
1.1. Antigenic Space. During a viral infection, antibodies bind to viral antigens by rec-
ognizing specific epitopes on their surface. The same antibody may provide protection
against other strains of the same virus if the antigens are not too dissimilar. In 1979, Alan
Perelson and George Oster defined the idea of antigenic space [PO79]. They supposed that
each antibody and antigen might be described by a vector in Rn. This idea was used as a
basis to study the dynamics of the immune response, with n assumed to be a small number
[SP89, DBSP92]. Subsequent work to estimate n based on the frequency of cross reactivity
resulted in the conclusion that n was around five to eight [SFHP97].
The notion of antigenic space has proven particularly popular for understanding the
evolution of influenza H3N2 [FWJ+14]. This strain has been circulating in the human
population since 1968 and gradually mutating. These mutations can in principle be rep-
resented as the movement of the virus through antigenic space. As the antigen moves it
can evade the antibodies elicited by older strains and thus reinfect individuals. The dis-
tance between a viral strain and an antibody can be measured via the hemagglutination
inhibition (HAI) assay, in which a viral strain and a serum of antibodies are both added
to a culture of red blood cells. If the antibodies are ineffective against the viral strain then
the virions stick to the red blood cells causing them to cluster together (hemagglutinate).
However if the antibodies are effective, they will neutralize the virions and inhibit their
hemagglutination of the red blood cells. In the former case, the strain and the serum
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are distant antigenically, whereas in the latter case they are close. By performing serial
dilutions of the antibody serum, one can quantify just how close a serum and antibody are.
Points in antigenic space can be inferred from a distance matrix via multidimensional
scaling (MDS). Low dimensional reconstructions of antigenic space can reproduce the HAI
data with high fidelity, and adding new dimensions beyond n = 5 does not improve the
quality of the fit [LF01, SLdJ+04]. Thus it may be tempting to conclude that influenza is
evolving in an antigenic space of no more than five dimensions.
1.2. Outline of results. In this work we will argue that influenza H3N2 is evolving in
a very high dimensional space, and that it may appear to be low dimensional due to the
nature of random walks. Our argument consists of three parts.
(1) High dimensional random walks contain most of their variance in a small number
of dimensions. Specifically, one would expect at least 60% of the variance to occur
in a single dimension. We show this via principal component analysis. However,
we note that the true dimensionality of random walks can be revealed by out of
sample PCA.
(2) This apparent low dimensionality also occurs with multidimensional scaling — the
method used to analyze HAI titer data. We simulate HAI data generated using a
high dimensional random walk and find we can accurately reproduce the data with
points taken from a low dimensional space; increasing the dimensionality of our
representation does not improve our fit. We also show that non-metric MDS can
be used to reconstruct an infinite dimensional random walk in a single dimension.
(3) Finally, we show that H3N2 data has characteristics of a high dimensional random
walk, indicating that it was unlikely to result from a random walk of dimensionality
less than n = 10. This is even the case when we consider that the random walk of
H3N2 is likely self avoiding.
1.3. Why a random walk? Throughout this paper we argue for a high dimensional
random walk as a model for influenza evolution. A random walk may seem a priori to
be a poor model for viral evolution, as immunological memory should prevent a virus
from revisiting areas of antigenic space. Therefore we should expect the path of viral
evolution to be self avoiding. In high dimensions an unbiased random walk and self avoiding
random walk will behave very similarly, because a high dimensional random walk is already
extremely unlikely to cross itself. In an n dimensional random walk the distance between
points i and j is a random variable Dij . Its distribution is
D2ij ∼ α|i− j|χ2n
where α is a constant of proportionality. This means that for large n the distances increase
in a very predictable manner as the χ2n distribution narrows. The probability of the random
walk approaching a previous point is essentially zero, so we need not include any further
tendency for self avoidance. However, in the latter part of the paper we will address the
question as to whether low dimensional self avoiding random walk could also be consistent
with the data.
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1.4. True dimensionality vs effective dimensionality. Let xi ∈ Rn represent distinct
viral strains and/or antisera. The antigenic dissimilarity of the two different strains xi and
xj is the euclidean distance Dij = ‖xi − xj‖2. Dij represents the true distance between
these two strains and n is the true dimensionality of antigen space.
If we can represent each point xi with a corresponding point yi ∈ Rk such that the
distances from yi to yj is approximately Dij , then we say that the effective dimensionality
of {xi} is k.
There are several possible ways to obtain the points yi and to evaluate how closely the re-
constructed distances match the true or measured distances. In this paper we shall make use
of three: classical MDS, metric MDS and nonmetric MDS. Classical MDS is also commonly
known as principal component analysis (PCA). The points yi are found by orthogonally
projecting the points xi onto the dimensions that contain the most variance. Metric MDS
simply minimizes the residual between the true distances and the reconstructed distances.
Non-metric MDS is similar to metric MDS but the relationship between the true distances
and the reconstructed distances is only assumed to be monotonically increasing as opposed
to directly proportional.
2. Results
2.1. Truly high dimensional random walks have low effective dimensionality
according to PCA. We will now show that random walks with high true dimension can
have a very low effective dimension. Our analysis will focus on infinite dimensional random
walks, but we will show via simulations that finite random walks have similar behavior.
Let xi ∈ Rn be the ith step in our random walk in n dimensions. Let X be an m by n
matrix whose ith row is xi. The rows of xi are determined by a seres of random steps
bi ∈ Rn, each entry of which is an independent sample from N (0, 1/
√
n)
x1 = b1(1)
xi − xi−1 = bi i > 1(2)
We can state this relationship compactly as LX = B, where the rows of B are bi and L is
an m by m matrix with one on the diagonal and negative one on the subdiagonal.
To perform PCA, we first center each column of X by premultiplying be the projection
matrix P = I − 1T1. Note that centering each column is just a translation of the data, so
all pairwise distances are preserved. We then compute the eigenvalues of A = PXXTP ,
λ1 > λ2 > · · ·λm. These eigenvalues indicate the variance in each principal component of
X. For this section we shall define effective dimension as
EDa = min
{
d :
k∑
i=1
λk ≥ a tr(A)
}
(3)
where 0 < a < 1 is the fraction of variance that we require within the first k dimensions.
The random matrix A = PL−1BBTL−TP is full rank and has a wishart distribution
if the number of steps is no greater than the number of dimensions, i.e. m ≤ n. If
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number of steps is greater than the number of dimension (n > m), A is singular and has a
pseudo-wishart distribution.
2.1.1. Infinite dimensional random walks. The matrixW = BBT is an uncorrelated Wishart
matrix. The joint probability distribution of the eigenvalues of Wishart matrices is known,
but the formula is cumbersome [Joh01, KA03, ZCW09]. Therefore we will focus our anal-
ysis on the limiting behavior as n → ∞, i.e. infinite dimensional random walks. As n
increases, W approaches the m by m identity matrix. (To see this, either note that the
i, jth entry of W is < bi, bj >). Using this simplification, the matrix A approaches
A = PL−1L−TP(4)
Noting that L−1 is an upper triangular matrix with all ones, we can calculate tr(A) =
(m− 1)(m+ 1)/6.
We can first observe that this matrix has one eigenvalue v = 1 with corresponding
eigenvalue λ1 = 0. To find the remaining eigenvalues we use the pseudo-inverse of A, A
†
which has the simple form
A† =


1 −1 0 · · · 0
−1 2 −1 . . . ...
0
. . .
. . .
. . . 0
...
. . . −1 2 −1
0 · · · 0 −1 1


(5)
The eigenvalues of this matrix are µs = 2 − 2 cos(pis/m). Therefore the eigenvalues of A
are
λk = 1/(2 − 2 cos(pis/m))(6)
The fraction of the variance in the first k dimensions is∑k
s=1 λs
tr(A)
=
∑k
s=1(1− cos(pis/m))−1
(m− 1)(m + 1) Finite m(7)
=
6
pi2
k∑
s=1
1/s2 Infinite m(8)
For infinite dimensional random walks, the first principal component contains at least 6/pi2
or roughly 60% of the total variance. The first two components contain 80% of the variance,
but the subsequent convergence is slow as 12 components are needed to account for 95% of
the variance (Fig. 2.1.1A,B). These numbers are the limiting behavior as the length of the
random walk grows. For shorter walks, more of the variance is in the first few components
(Fig. 2.1.1C, E) and thus the effective dimensionality may be even lower.
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Figure 1. Behavior of random walks A: The effective dimensionality
(the number of dimensions containing 95% of the variance) is always low,
even for high dimensional random walks. The horizontal line shows the the-
oretical limit of the effective dimensionality as n→∞. B: The cumulative
percentage of the total variance in the first 15 principal components or an in-
finite dimensional random walk. C/E: Percentage of variance in the first (C)
or first five (E) principal components vs number of steps in 10-dimensional
(black) or 100-dimensional (red) random walks. D/F:Percentage of variance
in the first (D) or first five (F) principal components vs number of dimension
in 100-step (black) or 1000-step (red) random walks.
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2.1.2. Finite dimensional random walks. In a finite number of dimensions n, the matrix A
is a random variable with a correlated Wishart or Pseudo-Wishart distribution. We there-
fore use simulation to investigate the effective dimensionality. As the true dimensionality
increases, the effective dimensionality asymptotically approaches the value for the infinite
case, in which 12 dimensions contain 95% of the variance. However, the effective dimen-
sionality for finite random walks is stochastic and in a few cases we find that it may exceed
12, although the mean is lower (Fig 2.1.1A).
Like the effective dimensionality, the percentage of variance in the first principal compo-
nent is a random variable, Ψ1. Regardless of the length of the walk or the true dimension-
ality, the mean of Ψ1 is very similar to the infinite dimensional case, and the variance of Ψ1
decreases with the true dimensionality but is independent on the length of the walk (Fig
2.1.1C,D). This gives the somewhat counter intuitive result that lower dimensional random
walks may have less variance in their first principal component than higher dimensional
walks. When we consider the percentage of variance in the first 5 components Ψ5, this
pattern disappears (Fig. 2.1.1E,F). The values of Ψ5 tend to decrease monotonically as
both the true dimensionality and the number of steps increase, asymptotically approaching
the prediction of roughly 89% from the infinite dimensional case.
2.1.3. True dimensionality of random walks can be revealed by subsampling. We have demon-
strated that when we perform PCA on a random walk, we find most of the variance in only
one dimensoin. Therefore, it is be difficult to tell whether the data originate from a high
or low dimensional random walk using PCA. In this section we demonstrate a way around
this problem using out of sample PCA.
We consider two scenarios: a uniform random walk in which movement in every direction
is equally likely, and a nonuniform random walk in which movement is ten times greater
— and thus the variance is 100 times greater — in 14 dimensions compared to the other
86. PCA finds the majority of variance is in the first dimension for both of these scenarios
(Fig 2.1.3). However if we take the projection matrix derived from performing PCA on the
first half of the random walk and apply it to the second half, we see that the bias towards
the first dimension largely disappears. The approximation improves further if we divide the
second half into subsequences, apply the projection to each subsequence and then average
the results (see methods for further details). This latter method shows clearly that in the
uniform random walk, each principal component has roughly the same variance. It also
captures the fact that 14 dimensions contain significantly more variance in the nonuniform
random walk. Therefore out of sample PCA can in principle allow one to recover the true
dimensionality of a random walk.
2.2. Truly high dimensional random walks look low dimensional according to
MDS.
2.2.1. H3N2 evolution. Derek Smith, Alan Lapedes and colleagues have used dimensional
reduction techniques to reconstruct two-dimensional antigenic maps of the evolution of
Influenza H3N2 [SLdJ+04]. In these maps, some points represent viruses whereas others
represent antisera. Distances can only be computed between a virus and an antisera as
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Figure 2. Out of sample PCA can recover true dimensionality We
can recover the true dimensionality of a random walk by performing out of
sample PCA. We split the walk into two halves. Performing PCA on the first
half tends to overestimate the variance in the first few principal components
(black dots). We then use the projection matrix derived fromPCA on the
first half to both the full second half of the random walk (red triangles) or
length 25 subsequences from the second half (blue crosses). We show the
variance estimated for each principal component in A) a uniform random
walk in 100 dimensions and B) a random walk 100 dimension where the
first 14 dimensions have 100 times as much variance as the remaining 86.
opposed to between different viruses directly. Thus classic MDS, which requires measured
distances between all pairs of points, cannot be used for this problem. Instead, they use
metric MDS with a slight modification to handle sub-threshold values. Using this method,
they have reconstructed a two-dimensional map of antigenic space. To validate this map,
they challenged it to predict the antigenic distance between strains and antisera that were
not used as inputs to build the map. They report a good correlation (roughly 80%) between
the predicted and actual values, and furthermore that the accuracy of their predictions is
similar for a two dimensional map and for higher dimensions. This is consistent with prior
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work showing that no more than five dimensions is required to satisfactorily reconstruct
HAI data [LF01].
Although these authors make no claims about the true dimensionality of the underlying
space, it may be tempting to conclude that antigenic space has a relatively low dimension-
ality. Our work, however, suggests that the antigenic space of H3N2 may appear to have
low dimensionality even though the true dimensionality is very high. We therefore created
artificial data to to mimic the evolution of H3N2 via a high dimensional random walk.
We then followed the procedure for evaluating the quality of reconstructions outlined in
[SLdJ+04].
(1) We partitioned the real and artificial distance matrices into a training set (90% of
the data) and a test set (10%)
(2) Using only the distances in the training set we reconstructed points in antigenic
space corresponding to each virus and serum. We varied the dimensionality of
antigenic space (k) between 2 and 20. Note our artificial data was created using
points in 100 dimensional space.
(3) We then uses the reconstructed points to predict the antigenic distances in the test
set. We evaluated the quality of these fits both by the root-mean-square error and
the correlation between the actual and predicted distance. These were the same
criteria used in [SLdJ+04].
We find that increasing k beyond 2, i.e. adding more dimensionality to our reconstructed
antigen space, did not improve the quality of the distance estimates (Fig 2.2.1A,B). This
suggests that even data originating from a high dimensional space can be approximated in
two dimensions.
2.2.2. An extreme case: High dimensional random walks can look one dimensional in non-
metric MDS. The goal of metric MDS is to find points x ∈ Rk whose pairwise euclidean
distances approximately match a set of given distances. In particular, the points x must
minimize the stress
Metric Stress =
√
(‖xi − xj‖ − dij)2∑
d2ij
(9)
where dij is the distance between point i and j.
In practice, the dij used as an input to MDS may not represent physical distances
but rather a generic measure of dissimilarity that does not behave like a metric. For
example, consider three points with dissimilarities d12 = 1, d23 = 2 and d13 = 100. The
dissimilarity cannot be a metric as it violates the triangle inequality. However, there may
be an underlying metric space that generated the points, and the underlying dissimilarity
represents a transformation, f , of that metric. The goal of non-metric MDS is to find both
f and values for x that minimize
Non-metric Stress =
√
(f(‖xi − xj‖)− dij)2∑
d2ij
(10)
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Figure 3. High dimensional walks can look low-dimensionWe used
multidimensional scaling to reconstruct maps of up to 20 dimensions from a
supplied distance matrix. We generated maps from H3N2 HI titer data, as
well as simulated data generated from a 100 dimensional random walk. We
tested the accuracy of these maps by training them on 90% of the data and
then using them to predict the remaining 10%. We plot the relative error
(A) and correlation between data and prediction (B) versus the number of
dimensionality of the map.
The distance-squared between steps in an n dimensional random walk follows a χ2n
distribution.
D2ij ∼ α|i− j|χ2n
where α is a constant of proportionality. In this case we let the dissimilarity dij be the
euclidean distance Dij . As n → ∞, the dissimilarity becomes exactly proportional to√|i− j|. Thus we can construct a one dimensional map of our random walk via
Dissimilarity between point i and point j d2ij = α|i− j|
Location of points xi = αi
Monotonic Transform f(·) = √·
(11)
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Plugging (11) into (10) we find that the stress is identically equal to zero. Therefore
an infinite dimensional random walk can be exactly represented in one dimension using
non-metric MDS.
2.3. Distinguishing between low dimensional and high dimensional random walks
using distance measures. So far we have demonstrated that high dimensional random
walks can appear low dimensional using methods such as MDS or PCA. We therefore ask
whether there is any good way to distinguish a low dimensional from a high dimensional
random walk. One characteristic of high dimensional random walks is the curve that forms
when the first two principal components are plotted against each other [Boo12]. This pat-
tern emerges as the number of dimensions approaches infinity. Fig. 2.3A shows the first two
principal components by year, whose path is reminiscent of the quadratic shape predicted
in [Boo12]. This pattern is suggestive of a high (FIg 2.3B), rather than low dimensional
(Fig 2.3C) random walk.
We next sought an objective measure to distinguish a low dimensional from high di-
mensional walk. Once again we take advantage of the fact that the square of the distance
between the ith and jth step in an n dimensional random walk is proportional to a χ2
distribution with n degrees of freedom.
D2ij ∼ α|i− j|χ2n(12)
Let D¯2s denote the average distance between two points separated by s steps, i.e.
D¯2s =
1
m− s
i−m+s∑
i=1
D2i,i+s(13)
where m is the number of steps. As n → ∞, the coefficient of variation of χ2n → 0, so
we should expect D¯2s ≈ αs for some α. In other words, for high dimensional random
walks plotting D¯2s vs s should give a linear relationship. We therefore grouped all antigenic
map points in the H3N2 data by year, representing both viral strains and anti-sera, and
computed the mean of each group. Computing the distance-squared between the annual
means and plotting versus the number of years elapsed does indeed produce a linear pattern.
In this regard, the H3N2 data once again qualitatively resembles a high dimensional random
walk rather than a low dimensional one.(Fig 2.3D-F).
To quantify this resemblance, let τ be the coefficient of variation of xs =
1
s
D¯2s , i.e
τ =
√√√√√
∑m−1
s=1 x
2
s(∑m−1
s=1 xs
)2 − 1(14)
For high dimensional random walks, we expect τ to be close to zero. We simulated τ for
large numbers of random walks and compared to the value computed for the H3N2 data
(Fig 2.3). We find that the H3N2 data is unlikely to have been produced by a random walk
of less than ten dimensions (n < 10). Note also that the value of τ for the data may be
inflated due to any number of sources of variability not accounted for in the model, such
HIGH DIMENSIONAL RANDOM WALKS CAN APPEAR LOW DIMENSIONAL 11
−10 −5 0 5
−
6
−
4
−
2
0
2
4
PC1
PC
2
H3N2 Data Random Walk (n=2) Random walk (n=100)
A
Annual Means
All Points
0 5 10 15 20 25 30 35
0
50
10
0
15
0
20
0
25
0
Years Elapsed
M
ea
n 
di
st
an
ce
 s
qu
ar
ed
D
−4 −2 0 2
−
3
−
2
−
1
0
1
2
3
PC1
PC
2
B
0 5 10 15 20 25 30 35
0
5
10
15
20
25
30
35
Number of Steps
M
ea
n 
di
st
an
ce
 s
qu
ar
ed
E
−30 −20 −10 0 10 20 30
−
15
−
10
−
5
0
5
10
15
PC1
PC
2
C
0 5 10 15 20 25 30 35
0
10
00
20
00
30
00
40
00
Number of Steps
M
ea
n 
di
st
an
ce
 s
qu
ar
ed
F
Figure 4. Distinguishing between high and low dimensional ran-
dom walks High dimensional random walks follow a characteristic para-
bolic curve when plotting the first two principal components (A,B,C). Fur-
thermore, the relationship between number of steps and distance squared
between two points is linear (D,E,F). The H3N2 antigen map (A,D) re-
sembles a 100-dimensional random walk (C,F) more than a 2-dimensional
random walk (B,E).
as measurement error or a heavy tailed distribution in annual step size. Therefore d = 10
is the lower bound for the dimensionality antigenic space and dimensionality of 30 or more
is quite likely. These findings extend to self avoiding random walks, as decribed in the
methods section, which behave similarly in this regard.
3. Discussion
High dimensional random walks can appear to be low dimensional. We have shown that
most of their variance will appear in a single principle component, and that their pointwise
distances can be well approximated by embedding in a two dimensional space. Therefore
when using principal component analysis (PCA) or multidimensional scaling (MDS) we
may erroneously find that only a few dimensions are important. We demonstrate that by
splitting the data set into two, we can use out of sample PCA to potentially recover the
true dimensionality of the random walk. If only MDS is possible, perhaps due to missing
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Figure 5. True dimensionality of antigenic is at least n = 10 We
measured deviation from a linear relationship between number of steps and
distance squared between points by dividing the latter by the former and
taking the coefficient of variation. The horizontal line shows the value found
for the H3N2 antigenic map, which is compared to the values found for 10000
simulated random walks of each of the indicated dimensions. We find that
the consistency of the linear trend as depicted in 2.3D is inconsistent with
a random walk of dimension less than 10.
data, we demonstrate that high dimensional and low dimensional random walks can be
distinguished by testing the relationship between distance and step number.
We apply these ideas to the evolution of influenza H3N2. Using data from the HAI assay
different strains from 1968 to 2003 can be readily represented in a two dimensional antigenic
map. The distances on this map represent the level of cross immunity that an antibody
response to one strain may provide against another. Given this it may be tempting to
conclude that influenza is constrained to move in a two dimensional space or at least is
biased to move in two dimensions. However, we caution that antigenic space may in fact
be very high dimensional or even infinite dimensional and we would still expect to be able
to reconstruct it in two dimensions. In fact, we find that a low dimensional random walk
or self avoiding random walk is very unlikely to have produced the H3N2 HAI titer data.
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One interesting aspect of influenza H3N2 evolution is that despite the annual variation
in strain, the strains have not been diverging. Different strains circulating in a given year
tend to be close together antigenically. There have been many models proposed to explain
this phenomenon [GG02, FGB03, KCGP06, BRP12, WSRG13]. Here we have only shown
that the data is consistent with a high dimensional random walk or self avoiding random
walk. We assume that the direction of the next step is equally likely to be in any direction,
provided that this does not bring the walk back to an already visited region. Therefore
our model is consistent with antigenic drift hypotheses as described in [GG02, FGB03,
KCGP06, BRP12] but not the antigenic thrift hypothesis described in [WSRG13].
4. Methods
4.1. Out of sample PCA.
(1) Start with a length 2m random walk in n dimensions.
(2) Split the random walk into two halves.
(3) Apply PCA to the first half. This will yield an orthogonal projection matrix P ∈
R
n×n which projects any point onto the principal component axis.
(4) Split the second half of the walk into subsequences with a short length, µ. These
subsequences consist of steps m + 1 to m + µ, m + µ + 1 to m + 2µ, etc. Let
Si ∈ Rn×µ denote the ith such subsequence.
(5) Apply P to each subsequence Si, i.e. compute Bi = PSi.
(6) Let σ2i be the variance of each row of Bi.
(7) Let σ2 = 1
ν
∑ν
i=1 σ
2
i be the sum of all i, where ν is the number of subsequences
(i.e. νµ = m).
4.2. Generating simulated data. We want to generate Nv viral strains and Ns antis-
era. We will represent each strain and antisera as a point in Rn, where d is our chosen
dimensionality of antigenic space. The generation of the artificial data makes repeated use
of random vectors in Rn. We draw these random vectors from N(0, Id), i.e. their entries
are i.i.d unit normal random variables. We first generate the viral strains via a random
walk. Let Vi ∈ Rn represent the ith viral strain in the walk, then
V1 = b1
Vi − Vi−1 = bi i > 1
where bi N(0, In)
Next we use these strains to randomly generate antisera. Let Sj ∈ Rn be the jth
antiserum, then
Sj = Vpj + b
where pj is a random integer between 1 and Nv and cj N(0, In).
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4.3. Multi Dimensional Procedure. In this paper we use the form of multidimensional
scaling described in [SLdJ+04]. We perform this scaling in two distinct cases: starting
from a matrix of measured HI and starting from artificial data generated as described in
the previous section.
Not every viral strain is measured against each serum. Let NMeas be the number of
measurements and let 0 < l ≤ NMeas index those measurements. We can then define
il Strain corresponding to the lth measurement
jl Serum corresponding to the lth measurement
dl Distance between strain il and serum jl
In the case of real HI titer data, we convert the titer to a distance using the method
described in [SLdJ+04]. When using artificial data, we simply compute dl = ‖Vil − Sjl‖.
Next we seek a set of points Vˆi ∈ Rk and Sˆj ∈ Rk that minimizes the objective function
F
(
{Vˆi}, {Sˆj}|{dl}, {il}, {jl}
)
=
NMeas∑
l=0
(
dl − ‖Vˆil − Sˆjl‖
)2
We use values of k between 2 and 20.
We minimize F numerically using the optim function in R. We use the BFGS method
and provide the analytically derived gradient of F for efficient computation. This is an
iterative algorithm that requires an initial guess. We generate these guesses using classic
MDS, which is equivalent to principal component analysis. The classic MDS algorithm
requires a complete distance matrix. In the case of the artificial data, we can calculate this
distance matrix directly. In the case of the real data, we construct a plausible distance
matrix by finding the shortest path between any two points whose distance was not directly
measured. Note that although this plausible distance matrix is likely incorrect, it is only
used to find a good starting guess for our algorithm. The solution found using this method
compared favorably to the solution found in [SLdJ+04]
4.4. Self avoiding random walk. The self avoiding random walk behaves similarly to
an unbiased random walk accept that the new steps are excluded from getting to close
to previous ones. Each new step in the walk is determined according to the following
algorithm.
(1) Given a current step xi, propose a new step xˆ = xi + b ∈ Rn, where the entries of
b are i.i.d with distribution N (0, 1/√n.
(2) Calculate the probability of acceptance via
P =
i∏
j=0
g(xˆ|xi)
g(xˆ|xi) = 1− e−‖xˆ−xi‖2
(3) With probability P accept the new step and let xi+1 = xˆ. With probability 1− P
return to step one and propose a new step.
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